Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/13/2019
As Trade War Continues, Pharma Companies Prepare for Alternatives
11/12/2019
Upcoming Event: 2019 Pharma CI+MR Asia Conference & Exhibition
11/12/2019
A Summary of The Latest Amendments to the Guidelines for Patent Examin...
11/12/2019
NMPA Announces Implementation of 15 Series E and 13 Series S ICH Guide...
11/12/2019
GSK Announces Chinese Approval of Triple COPD Therapy Trelegy Ellipta
11/12/2019
GE Healthcare and Akeso Expedite Antibody Manufacturing in China
11/11/2019
Chi-Med Announces NDA Acceptance for Novel Drug Surufatinib
11/11/2019
Akesobio Presents P1 Data from First-in-class Bispecific Drug Candidat...
11/11/2019
Novaliq, Hengrui Enter China licensing Deal for EyeSol-based NOV03 and...
11/11/2019
NHSA Initiates A New Round of Negotiation for the NRDL Access
11/11/2019
CDE Extends Deadline for Public Comments on Nine Draft Documents
11/11/2019
CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
11/8/2019
NDRC Issues the Work Plan for Building Regional Medical Centers
11/8/2019
CDE Solicits Public Comments on the Working Process for Priority Revie...
11/8/2019
CDE Solicits Public Comments on the Working Process for Breakthrough M...
11/8/2019
CDE Solicits Comments on Revised Draft of the Technical Guidelines for...
11/8/2019
CDE Solicits Comments on Two Technical Guidelines for Pharmaceutic Cha...
11/8/2019
CDE Issues Two Draft Clinical Research Management Documents for Public...
11/8/2019
NHC Issues Notice to Establish National and Regional Mental Medicine+C...
11/7/2019
Biogen and Samsung Expand Biosimilar Deal to Cover China and More Prod...
11/7/2019
Tot Biopharm Raises $75.2M in Hong Kong IPO
11/7/2019
CASI Pharma Enters Exclusive China Distribution License Agreement
11/7/2019
Restrictions and Conflicts - Challenges Faced by Pharmaceutical Tradem...
11/7/2019
Novartis, Tencent Co-launch Online Platform for Chinese Heart Disease ...
11/7/2019
Novartis Sign Numerous Eye Health Deals with Local Partners at CIIE
11/7/2019
Antengene Announces Exclusive Worldwide License for AstraZeneca's AZD0...
11/7/2019
Top Execs from AstraZeneca, Roche, Sanofi and GSK Tout China Investmen...
11/7/2019
Sun Pharma, AstraZeneca Enter Licensing Deal to Market Novel Oncology ...
11/7/2019
MD Anderson Inks In-licensing Deal with Artios and ShangPharma
11/7/2019
AstraZeneca Announces Three Large-Scale Initiatives in China to Advanc...
Page:
205
/
720
Total number of articles:
21572
:
[First]
[<<]
[203]
[204]
[205]
[206]
[207]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit